References
Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–75. https://doi.org/10.1001/jama.2011.90.
Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303–10. https://doi.org/10.1016/S1470-2045(14)70460-7.
Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14(4):297–305. https://doi.org/10.1016/S1470-2045(13)70035-4.
Stafford AP, Hoskin TL, Day CN, Sanders SB, Boughey JC. Contemporary axillary management in cT1–2N0 breast cancer with 1–2 positive sentinel lymph nodes: factors associated with completion axillary lymph node dissection within the National Cancer Database. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11759-y.
Network NCC (version 2.2022). https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed 2 Mar 2022.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors have no conflicts of interest or sources of funding to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Stafford, A.P., Hoskin, T.L., Day, C.N. et al. ASO Author Reflections: Axillary Management in Mastectomy Patients with Limited Nodal Burden. Ann Surg Oncol 29, 4750–4751 (2022). https://doi.org/10.1245/s10434-022-11826-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-11826-4